Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $380

Benzinga Newsdesk www.benzinga.com Positive 63.3%

Neg 0% Neu 0% Pos 63.3%

Barclays analyst Emily Field maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $360 to $380.